6615 Stock Overview
Provides genetic testing services in Taiwan and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Sofiva Genomics Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$39.95 |
| 52 Week High | NT$86.00 |
| 52 Week Low | NT$38.45 |
| Beta | 0.30 |
| 1 Month Change | 0% |
| 3 Month Change | -14.27% |
| 1 Year Change | -12.00% |
| 3 Year Change | -17.37% |
| 5 Year Change | -38.54% |
| Change since IPO | -56.10% |
Recent News & Updates
Recent updates
Some Investors May Be Worried About Sofiva GenomicsLtd's (GTSM:6615) Returns On Capital
Apr 14
Estimating The Fair Value Of Sofiva Genomics Co.,Ltd. (GTSM:6615)
Mar 18Sofiva Genomics Co.,Ltd. (GTSM:6615) Investors Should Think About This Before Buying It For Its Dividend
Feb 24Should Weakness in Sofiva Genomics Co.,Ltd.'s (GTSM:6615) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jan 27Our Take On The Returns On Capital At Sofiva GenomicsLtd (GTSM:6615)
Jan 07
A Look At The Intrinsic Value Of Sofiva Genomics Co.,Ltd. (GTSM:6615)
Dec 15Read This Before Buying Sofiva Genomics Co.,Ltd. (GTSM:6615) For Its Dividend
Nov 24Shareholder Returns
| 6615 | TW Healthcare | TW Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | -12.0% | -11.8% | 28.6% |
Return vs Industry: 6615 matched the TW Healthcare industry which returned -11.8% over the past year.
Return vs Market: 6615 underperformed the TW Market which returned 28.6% over the past year.
Price Volatility
| 6615 volatility | |
|---|---|
| 6615 Average Weekly Movement | 3.4% |
| Healthcare Industry Average Movement | 3.6% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in TW Market | 7.8% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 6615 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 6615's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | n/a | Chia-Cheng Hung | www.sofivagenomics.com.tw |
Sofiva Genomics Co.,Ltd. provides genetic testing services in Taiwan and internationally. The company offers prenatal services, including thalassemia carrier screening; tests for microdeletion syndromes and single-gene abnormalities; detection of common chromosome abnormalities, selected microdeletions syndromes, and selected skeletal dysplasia genetic mutations; multiple genetic diseases detection; folate metabolism genetic screening; spinal muscular atrophy carrier screening; fragile X syndrome carrier screening; congenital infection screening; risk assessment for early/late-onset preeclampsia; maternal serum screening for down syndrome; and karyotyping.
Sofiva Genomics Co.,Ltd. Fundamentals Summary
| 6615 fundamental statistics | |
|---|---|
| Market cap | NT$862.66m |
| Earnings (TTM) | NT$21.08m |
| Revenue (TTM) | NT$464.66m |
40.9x
P/E Ratio1.9x
P/S RatioIs 6615 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6615 income statement (TTM) | |
|---|---|
| Revenue | NT$464.66m |
| Cost of Revenue | NT$327.05m |
| Gross Profit | NT$137.61m |
| Other Expenses | NT$116.53m |
| Earnings | NT$21.08m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.98 |
| Gross Margin | 29.62% |
| Net Profit Margin | 4.54% |
| Debt/Equity Ratio | 0% |
How did 6615 perform over the long term?
See historical performance and comparisonDividends
0.5%
Current Dividend Yield20%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/30 03:25 |
| End of Day Share Price | 2025/01/22 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sofiva Genomics Co.,Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yenya Kuo | Capital Securities Corporation |
| Xiaowei Huang | Masterlink Securities Corp. |